Cardionomic completes enrolment for cardiac neurostimulation device trials
The studies enrolled 35 patients across various countries, with data scheduled for publication this year.
05 January 2024
05 January 2024
The studies enrolled 35 patients across various countries, with data scheduled for publication this year.
The US-based trial was able to lower anxiety in patients living with a condition that has no curative treatment using a nine-week course of cognitive therapy.
Training and validation of SimpleSense-BP were carried out in diverse geographic and demographic populations.
The new cellular-connected remote patient monitoring devices are designed to enhance connectivity and ease of use.
The MAGNETOM Cima.X scanner comprises Gemini Gradients with an amplitude of 200 milliteslas per metre (mT/m).
Geneseeq's CanScan device can detect early cancer signals with 99% specificity in peripheral blood.
SpineX is planning to start recruitment for a pivotal trial in children with cerebral palsy in the first half of this year.
Renovite BMP-2 is made from a synthetic nanoclay gel, designed to be safer and more effective than current bone graft materials.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest thematic report will help you to understand and identify the important themes that threaten to disrupt your business in 2024. Our 2024 theme map covers not only disruptive tech themes but also ESG, macroeconomic, and regulatory themes. Reading this report is the first step towards making better business decisions in 2024.
Give your business an edge with our leading industry insights.